The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•23 March 2026•

1 min read

NRx Pharmaceuticals Reports Surprise Q4 Profit, Significantly Beating Analyst Estimates

Key Facts

1NRx Pharmaceuticals reported quarterly earnings of $0.19 per share.

2The results beat the Zacks Consensus Estimate which projected a loss of $0.09 per share.

Version History

2 additional sources confirmed this story

NRx Pharmaceuticals (NRXP) announced its fourth-quarter financial results, delivering a significant earnings surprise to the market. The company reported quarterly earnings of $0.19 per share, marking a major shift into profitability. This result substantially outperformed the Zacks Consensus Estimate, which had projected a net loss of $0.09 per share. The performance represents a dramatic year-over-year improvement compared to the $0.30 per share loss recorded in the same period last year. This unexpected transition to profitability serves as a strong positive catalyst for the pharmaceutical firm's stock. Investors are closely monitoring the company's trajectory as it moves away from its previous loss-making position.